Jennison Associates’s Derma Sciences DSCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-1,412,577
Closed -$7.34M – 860
2016
Q4
$7.34M Buy
1,412,577
+2,909
+0.2% +$13.7K 0.01% 496
2016
Q3
$6.58M Sell
1,409,668
-3,866
-0.3% -$18K 0.01% 497
2016
Q2
$5.57M Sell
1,413,534
-953
-0.1% -$3.56K 0.01% 496
2016
Q1
$4.38M Buy
1,414,487
+6,981
+0.5% +$23.4K ﹤0.01% 495
2015
Q4
$6.43M Buy
1,407,506
+261,818
+23% +$1.24M 0.01% 505
2015
Q3
$5.4M Buy
1,145,688
+5,242
+0.5% +$33.8K 0.01% 540
2015
Q2
$8.17M Buy
1,140,446
+3,518
+0.3% +$26.5K 0.01% 524
2015
Q1
$9.6M Buy
1,136,928
+262
+0% +$2.23K 0.01% 497
2014
Q4
$10.6M Sell
1,136,666
-12,648
-1% -$110K 0.01% 483
2014
Q3
$9.6M Buy
1,149,314
+1,374
+0.1% +$12.7K 0.01% 485
2014
Q2
$13.3M Sell
1,147,940
-123,981
-10% -$1.27M 0.01% 463
2014
Q1
$16.1M Buy
1,271,921
+3,449
+0.3% +$44.6K 0.02% 459
2013
Q4
$13.7M Buy
1,268,472
+4,010
+0.3% +$46.6K 0.01% 469
2013
Q3
$15.7M Sell
1,264,462
-3,585
-0.3% -$49.6K 0.02% 454
2013
Q2
$16.9M Buy
+1,268,047
New +$16.3M 0.02% 445

Other funds holding DSCI

Jennison Associates's DSCI Position: Q1 2017 in Review

Jennison Associates sold out of Derma Sciences (DSCI) in Q1 2017, closing a stake of 1,412,577 shares — an estimated $7.34M sold.

Jennison Associates first reported a position in DSCI in Q2 2013 and held it in 15 quarters. The position peaked at $16.9M in Q2 2013. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Jennison Associates reported no remaining Derma Sciences position as of Q1 2017 after selling out during the quarter.
  • Jennison Associates sold 1,412,577 Derma Sciences shares in Q1 2017, an estimated $7.34M.
  • Jennison Associates first reported a position in Derma Sciences in Q2 2013 and held it in 15 quarters.
  • Jennison Associates's Derma Sciences position peaked at $16.9M in Q2 2013.
  • 1 fund tracked by Wall St. Rank held Derma Sciences as of Q1 2017.

Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.